About
Virtual screening and fragment-based screening methods, including Weak Affinity Chromatography (WAC), are efficient and informed methods for hit identification. However, advancing drug discovery programs beyond the initial screening hits remains a challenge. Employing workflows that fully leverage available data maximize the chances of success and can uncover new opportunities.

In this webinar, Dr. Björn Borgström will share real-world examples of how innovative and resource-efficient workflows have been used by the Drug Discovery Team at RG Discovery to overcome challenges and accelerate project progression. Through case studies, attendees will gain practical insights into decision-making processes that enable rapid and cost-effective advancement of drug discovery programs.

Key Topics:

  • Creative and pragmatic approaches to kickstart projects in early-stage drug discovery programs.

  • Strategies for efficient hit identification, illustrated through case studies targeting CDK9 and SMARCA4.

  • How CETSA-based selectivity profiling can reveal potential liabilities and identify opportunities early in a project.

When
Thursday, November 5, 2026 · 11:00 a.m. Eastern Time (US & Canada) (GMT -5:00)
Presenter
1790867098-cd65cc9b280877ce
Björn Borgström, PhD
Team Manager, Drug Discovery, RG Discovery (part of Pelago Bioscience since June 2026)
Dr. Björn Borgström is head of Drug Discovery at RG Discovery. Since joining the company as a Medicinal Chemist following his graduation from Lund University, Sweden, he has played a key role in advancing drug discovery programs across multiple therapeutic areas. Over the past decade, he has led and contributed to projects from hit identification through lead optimization, supporting the development of novel therapies for oncology, metabolic diseases, and inflammatory disorders. He has co-authored 10 peer-reviewed publications and is an inventor on five patents.
Reserve Your Spot
First Name*
Last Name*
Email Address*
Country / Region*
Job Title*
Organization / Company*
Organization Type*
Your Therapeutic Area(s)*
utm_bmcr_source
Registration Terms
This event is hosted by Scientist.com. By registering and participating, you acknowledge that your personal data will be processed by Scientist.com. You also agree to receive email communication from Scientist.com about this webinar and other programs of similar nature. The sponsor of this webinar is Pelago Bioscience; by registering and participating, you acknowledge that your data will be processed in accordance with Pelago Bioscience’s Privacy Policy. You will receive email communication from Pelago Bioscience about this webinar and programs of similar interest. You can withdraw your consent at any time from these communications.
Scientist.com Privacy Policy
✓ Yes, I consent to the registration terms.*
Pelago Bioscience Privacy Policy
✓ Yes, I consent to the registration terms.*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
Powered by BigMarker